CU Cancer Center’s D. Ross Camidge, MD, PhD, Honored by the International Association for the Study of Lung Cancer(IASLC)

Camidge received the organization’s Daniel C. Ihde Lectureship Award for Medical Oncology

CU Cancer Center’s D. Ross Camidge, MD, PhD, Honored by the International Association for the Study of Lung CancerUniversity of Colorado Cancer Center member Ross Camidge, MD, PhD, has seen huge advances in lung cancer treatment during his years in the field. As he put it in a recent address, “not that long ago, and still for many with lung cancer, their new diagnosis feels like looking down the barrel of a gun. Yet at the same time we can now also fill a room with select long-term survivors of the disease.”

Dr. Camidge, the Joyce Zeff Chair in Lung Cancer Research in the CU School of Medicine, delivered that speech, titled “Evolving Expectations,” in Singapore in September at the annual World Conference on Lung Cancer. The event is hosted each year by the International Association for the Study of Lung Cancer, which this year honored Camidge with its Daniel C. Ihde Lectureship Award for Medical Oncology. The award is named for the influential lung cancer researcher and former longtime deputy director of the National Cancer Institute. See the award presentation and lecture video by Dr. Camidge during IASLC.

Dr. Camidge also serves as the distinguished Director of the ATOMIC Consortium, dedicated to Translational Research in multi-center clinical trials for lung and thoracic cancers.

Read the full article here: https://news.cuanschutz.edu/cancer-center/ross-camidge-iaslc

Article courtesy of CU Anschutz News (by Greg Glasgow) Used by permission

Recommended Posts